Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
scientific article published on 17 March 2017
Author/s
author: Philippe Gabriel Steg, Héctor Bueno, Christoph Bode, Gilles Montalescot, Erik Magnus Ohman, Matthew T Roe, Michał Tendera, Frank W Rockhold, Robert Welsh, Jan H Cornel, José Carlos Nicolau, Marc J Claeys, Steen E Husted, Thomas J Povsic, John T Strony, Stefan James, Shinya Goto, Diego Ardissino
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.